Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
Tabla de Políticas Médicas
| ID | Título | Revisión | Descripción | Acceso |
|---|---|---|---|---|
| 05.001.012 | (Trastuzumab) Herceptin | Sep 2025 | In certain cancers, the human epidermal growth factor receptor 2 (her2) gene is amplified and overexpressed.... | Ver |
| 05.001.014 | Intravenous Anesthetics For The Treatment Of Chronic Pain And Psychiatric Disorders | Dec 2025 | Intravenous (iv) infusion of lidocaine or ketamine has been investigated for the treatment of migraine and... | Ver |
| 05.001.015 | Advanced Therapies For Pharmacologic Treatment Of Pulmonary Hypertension | Dec 2025 | Pulmonary hypertension (ph) is a chronic, progressive condition characterized by abnormally high pulmonary... | Ver |
| 05.001.016 | Uses Of Monoclonal Antibodies For The Treatment Of Non-Hodgkin Lymphoma | Dec 2024 | Monoclonal antibodies targeted to cancer-associated antigens have been approved by the u.s. food and drug... | Ver |
| 05.001.017 | Bevacizumab | Dec 2025 | Bevacizumab is a humanized monoclonal antibody directed against vascular endothelial growth factor a... | Ver |
| 05.001.019 | ABATACEPT (ORENCIA) | Dec 1969 | From the decade of 1990 the advances in molecular biology have shown new approaches to the treatment for... | Ver |
| 05.001.021 | Vandetanib | Oct 2024 | The medication vandetanib is an inhibitor of the "tyrosine kinase" which is selectively targeted to... | Ver |
| 05.001.023 | Newer Oral Anticoagulants | Jul 2020 | ... | Ver |
| 05.001.024 | Ado-Trastuzumab Emtansine (Trastuzumab-Dm1) For Treatment Of Her2-Positive Malignancies | Aug 2025 | Ado-trastuzumab emtansine, also known as trastuzumab-dm1 (t-dm1), is an antibody-drug conjugate that links... | Ver |
| 05.001.026 | Pertuzumab For Treatment Of Malignancies | Nov 2025 | Pertuzumab (perjeta), a monoclonal antibody, is a human epidermal growth factor receptor 2 (her2) antagonist.... | Ver |
| 05.001.028 | Treatment For Spinal Muscular Atrophy | Apr 2026 | Spinal muscular atrophy is an inherited disorder caused by homozygous deletions or variants in the smn1 gene.... | Ver |
| 05.001.029 | Nononcologic Uses Of Rituximab | Nov 2025 | ... | Ver |
| 05.001.030 | Testosterone Replacement Therapies | Jan 2026 | Testosterone replacement therapy is the primary treatment for androgen deficiency in men. testosterone... | Ver |
| 05.001.031 | Treatment For Duchenne Muscular Dystrophy | Feb 2026 | Duchenne muscular dystrophy is an inherited disorder that results in progressive muscle weakness and loss of... | Ver |
| 05.001.032 | Buprenorphine Implant For Treatment Of Opioid Dependence | Oct 2025 | Buprenorphine is a partial μ-opioid agonist used to treat patients with an opioid addiction. administered... | Ver |
| 05.001.033 | Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adult Patients | Jul 2025 | Hereditary transthyretin-mediated amyloidosis (hattr) is a rare, progressive, and fatal autosomal dominant... | Ver |
| 05.001.034 | Tropomyosin Receptor Kinase Inhibitors For Locally Advanced Or Metastatic Solid Tumors Harboring An Ntrk Gene Fusion | Apr 2024 | The tropomyosin receptor kinase (trk)-receptor family is encoded by the 3 neurotrophic receptor tyrosine... | Ver |
| 05.001.035 | Monoclonal Antibody Therapies For Migraine and Cluster Headache | Jan 2026 | Migraine is a headache disorder characterized by recurrent moderate to severe headaches with associated... | Ver |
| 05.001.036 | Brexanolone For Postpartum Depression | Sep 2025 | Postpartum depression (ppd) is a serious and debilitating condition that is characterized by a major... | Ver |
| 05.001.037 | Medical Cannabis For The Treatment Of Pain And Spasticity | Sep 2023 | Cannabis describes organic products (eg, cannabinoids, marijuana, hemp) that are derived from the cannabis... | Ver |